Propranolol in portal hypertension. 1983

G Menghini

UI MeSH Term Description Entries
D006975 Hypertension, Portal Abnormal increase of resistance to blood flow within the hepatic PORTAL SYSTEM, frequently seen in LIVER CIRRHOSIS and conditions with obstruction of the PORTAL VEIN. Cruveilhier-Baumgarten Disease,Cruveilhier-Baumgarten Syndrome,Cruveilhier Baumgarten Disease,Cruveilhier Baumgarten Syndrome,Disease, Cruveilhier-Baumgarten,Portal Hypertension,Portal Hypertensions,Syndrome, Cruveilhier-Baumgarten
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

G Menghini
May 1981, Lancet (London, England),
G Menghini
January 1983, Hepatology (Baltimore, Md.),
G Menghini
June 1981, Lancet (London, England),
G Menghini
May 1992, Journal of hepatology,
G Menghini
January 1988, Hepatology (Baltimore, Md.),
G Menghini
August 1980, Lancet (London, England),
G Menghini
January 1984, Hepatology (Baltimore, Md.),
G Menghini
October 1982, Lancet (London, England),
G Menghini
February 1985, The Journal of pediatrics,
G Menghini
January 1990, The National medical journal of India,
Copied contents to your clipboard!